Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danilo Menichelli

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Mayo Clinic Proceedings|December 16, 2018
Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study CohortDaniele Pastori, Pasquale Pignatelli, Danilo Menichelli, et al.
European Journal of Internal Medicine|August 30, 2023
Renin-angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registryDanilo Menichelli, Daniela Poli, Emilia Antonucci, et al.
Journal of Alzheimer'S Disease : JAD|May 20, 2019
Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic ReviewTommaso Bucci, Danilo Menichelli, Pasquale Pignatelli, et al.
European Journal of Internal Medicine|December 28, 2020
The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF studyDaniele Pastori, Danilo Menichelli, Francesco Violi, et al.
Thrombosis Research|August 29, 2023
Factor V Leiden, prothrombin, MTHFR, and PAI-1 gene polymorphisms in patients with arterial disease: A comprehensive systematic-review and meta-analysisEmanuele Valeriani, Daniele Pastori, Giulia Astorri, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 14, 2023
Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registryDanilo Menichelli, Emilia Antonucci, Pasquale Pignatelli, et al.
Haematologica|February 1, 2020
Seronegative antiphospholipid syndrome: refining the value of "non-criteria" antibodies for diagnosis and clinical managementPasquale Pignatelli, Evaristo Ettorre, Danilo Menichelli, et al.
European Journal of Clinical Investigation|September 8, 2020
Direct oral anticoagulants and advanced liver disease: A systematic review and meta-analysisDanilo Menichelli, Vincenzo Ronca, Arianna Di Rocco, et al.
Current Problems in Cardiology|March 25, 2019
Update and Unmet Needs on the Use of Nonvitamin K Oral Anticoagulants for Stroke Prevention in Patients With Atrial FibrillationDanilo Menichelli, Evaristo Ettorre, Arianna Pani, et al.
European Journal of Clinical Pharmacology|March 5, 2023
Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analysesGianluca Gazzaniga, Danilo Menichelli, Francesco Scaglione, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Mayo Clinic Proceedings|December 16, 2018
Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study CohortDaniele Pastori, Pasquale Pignatelli, Danilo Menichelli, et al.
European Journal of Internal Medicine|August 30, 2023
Renin-angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registryDanilo Menichelli, Daniela Poli, Emilia Antonucci, et al.
Journal of Alzheimer'S Disease : JAD|May 20, 2019
Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic ReviewTommaso Bucci, Danilo Menichelli, Pasquale Pignatelli, et al.
European Journal of Internal Medicine|December 28, 2020
The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF studyDaniele Pastori, Danilo Menichelli, Francesco Violi, et al.
Thrombosis Research|August 29, 2023
Factor V Leiden, prothrombin, MTHFR, and PAI-1 gene polymorphisms in patients with arterial disease: A comprehensive systematic-review and meta-analysisEmanuele Valeriani, Daniele Pastori, Giulia Astorri, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 14, 2023
Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registryDanilo Menichelli, Emilia Antonucci, Pasquale Pignatelli, et al.
Haematologica|February 1, 2020
Seronegative antiphospholipid syndrome: refining the value of "non-criteria" antibodies for diagnosis and clinical managementPasquale Pignatelli, Evaristo Ettorre, Danilo Menichelli, et al.
European Journal of Clinical Investigation|September 8, 2020
Direct oral anticoagulants and advanced liver disease: A systematic review and meta-analysisDanilo Menichelli, Vincenzo Ronca, Arianna Di Rocco, et al.
Current Problems in Cardiology|March 25, 2019
Update and Unmet Needs on the Use of Nonvitamin K Oral Anticoagulants for Stroke Prevention in Patients With Atrial FibrillationDanilo Menichelli, Evaristo Ettorre, Arianna Pani, et al.
European Journal of Clinical Pharmacology|March 5, 2023
Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analysesGianluca Gazzaniga, Danilo Menichelli, Francesco Scaglione, et al.
Pageof 10